NIH-funded research R01 grant

Noncoding RNAs that help protect the brain in Alzheimer's

Official title: Non-coding RNAs in resilience to Alzheimer’s Disease

Funded at Beth Israel Deaconess Medical Center · NIH-11299008 · Data updated 2026-11-12

This work looks at tiny RNA molecules that might help some older people keep their memory despite Alzheimer's brain changes.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBeth Israel Deaconess Medical Center
NIH-funded
Lab location1 site (Boston, United States)
Project startMay 15, 2023
Project endFebruary 28, 2028
Funding year2026
Award (this year)$844,278
NIH project number5R01AG082093-04
Project IDNIH-11299008 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are older adults with evidence of Alzheimer's brain changes—such as biomarkers or imaging—who remain cognitively intact, or people willing to provide samples for research.

Less likely to help

People with advanced Alzheimer's and substantial existing cognitive decline are unlikely to receive direct benefit from this early-stage research.

What this research studies

This project searches for small noncoding RNAs that appear to give some older adults resilience against cognitive decline even when their brains show Alzheimer’s pathology. Researchers will compare biological samples from resilient individuals to those with cognitive decline and use laboratory 3-D brain cell models to test how these RNAs affect cells. They will map the genes and stress-response pathways controlled by protective RNAs and test whether changing these RNAs alters resilience in model systems. The team aims to identify RNA targets that could be boosted or mimicked to help preserve memory.

Why it matters

Potential benefit: If successful, this work could point to RNA-based targets or treatments that strengthen the brain's resistance to Alzheimer's-related memory loss.

How similar studies have gone: Early research shows noncoding RNAs can affect brain aging and stress responses, but translating those findings into human treatments is still new and largely unproven.

Where this research is happening

  • Beth Israel Deaconess Medical Center
    Boston, United States
    Active

Researchers

  • Principal investigator: Slack, Frank J. — Beth Israel Deaconess Medical Center
  • Study coordinator: Slack, Frank J.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.